premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

KNT has been producing gold in Papua New Guinea since 2018 and recently reported a 71% increase in Q1 production, just as gold hits all-time high prices.  Cash flow is so strong, they are able to build reserves while aggressively deploying capital on project expansions.  It trades at 20x earnings and supports a ROE of 26%.  We recommend setting a stop-loss at $9.50, looking to achieve $16.00 -- upside potential of 30%.  Yield 0% 

(Analysts’ price target is $16.11)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

HUT operates energy infrastructure platforms for the development of data centres and bitcoin mining in North America.  It recently announced it has created "American Bitcoin" in conjunction with Eric Trump.  It trades at 4x earnings, 1.3x book and supports a 45% ROE.  We recommend setting a stop-loss at $10, looking to achieve $24 -- upside potential of 28%.  Yield 0%

(Analysts’ price target is $41.67)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

HPS manufacturers electrical transformers such as those used in data centres with plants in Canada, the US, Mexico and India.  Recently reported earnings showed record sales with 11% growth over the yar.  It trades at 15x earnings, 3.5x book and supports a ROE of 26%.  We recommend setting a stop-loss at $70, looking to achieve $119 -- upside potential of 28%.  Yield 1.2%.  

(Analysts’ price target is $160.50)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Jan 16/25, Up 14.8%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with GSK is progressing well.  To remain disciplined, we recommend trailing up the stop (from $27) to $32 at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 27/25, Up 10.1%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with MST is progressing well.  To remain disciplined, we recommend trailing up the stop (from $340) to $374 at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 27/25, Up 7.8%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with BKNG is progressing well.  To remain disciplined, we recommend trailing up the stop (from $3600) to $4000 at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Nov 12/24, Up 6.8%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with PET is progressing well.  To remain disciplined, we recommend trailing up the stop (from $20) to $23 at this time.  

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 20/25, Up 7.1%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with RMD is progressing well.  To remain disciplined, we recommend trailing up the stop (from $190) to $209 at this time.  

COMMENT
GDP numbers in US.

Here's his contrarian view...there is no trade war. It's just Trump mouthing off. He's said he's going to do some things, various people have responded, not much has happened, just a lot of talk. All this has seriously impacted the GDP numbers. 

The business and consumer sectors are OK in the US, but the import sector was terrible. Consequently, there was a slight decline in the GDP number. While bad, it was mostly because people were pre-buying and importing prior to tariffs. Trump kills the tariffs, makes deals, all that stuff goes away.

The big thing is that the response to his "trade war" has been universally bad -- to the MAGA people, to consumers, to businesses, to investors. (If there's any other group that he missed, it's universally bad to them too.) So the expectation is that he's going to have to correct it. Trump's people have announced that the next 100 days will be about trade deals and tax breaks. No matter what happens, Trump will declare he made the best deal ever.

COMMENT
Carney meets Trump next week.

For some reason, Trump hated Trudeau and, apparently, likes Carney. If you look at per capita GDP for the US vs. Canada, from 1990 to 2015, the lines are right on top of each other. Absolutely identical. From 2015, they start to diverge. 

Increase in per capita GDP for Canada since then has been 1.1%, not per year but total. In the US it's 52%. The difference is due to Canadian policy. This is not lost on anybody, including the new prime minister. Richard expects that economic policy and economic growth will be his #1 agenda item and that they will fix this. He's really positive on Canada because he thinks that's going to happen.

BUY

Got crushed at the start of the year. Current share price not very expensive. Dynamic US business. Really good CEO. As long as you take a multi-year view, doesn't see how you can possibly go wrong.

WAIT
AMZN vs. AAPL

The consumer-related companies are taking it on the chin, so AMZN's retail side is taking a hit. Cloud business is great. Imports all its goods, and can more easily switch to importing from countries other than China. He's not buying much of anything now, but if he were, he'd probably pick this one.

DON'T BUY
AAPL vs. AMZN

The consumer-related companies are taking it on the chin. In transition -- can they produce in the US or not? From  what he understands, moving manufacturing to the States would increase the cost of products dramatically. Getting crushed in China from competition. Tougher to change course.

AMZN's retail side is taking a bit of a hit. Cloud business is great. Imports all its goods, and can more easily switch to importing from countries other than China. He's not buying much of anything now, but if he were, he'd probably pick this one.

DON'T BUY
Why doesn't it get more traction?

The insurance business, in general, is not expanding dramatically. You get the nice dividend, which means they're not investing in the business. And they don't invest in the business because there's really nowhere to put their money for a high ROIC. Highly regulated, higher interest rates have a negative impact.

For him, the dividend is not a reason to buy things. Doing a good job, but there are better places to invest in financial services.

DON'T BUY

Great business, great management. Expensive. Off his radar unless the price changed a lot. Seven & I deal is great if they can do it. These guys are big, and he likes companies where there's lots of market opportunity ahead.